Robert Ehehalt
Minden, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
68Ga-FAPI PET/CT for non-invasive characterization and activity assessment of ulcerative colitis and Crohn´s disease.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 08, 2025
Real-world effectiveness of ustekinumab versus anti-TNF or vedolizumab in ulcerative colitis: induction and 12-month maintenance results from the prospective, observational RUN-UC study.
Journal: Journal of Crohn's & colitis
Published: March 28, 2025
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-Study.
Journal: Inflammatory bowel diseases
Published: January 23, 2023
Real-world effectiveness of vedolizumab compared to anti-TNF agents in biologic-naïve patients with ulcerative colitis: A two-year propensity-score-adjusted analysis from the prospective, observational VEDOIBD -study.
Journal: Alimentary pharmacology & therapeutics
Published: December 23, 2022
Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review.
Journal: Therapeutic advances in gastroenterology
Published: April 21, 2020
Interdisciplinary Aspects of Chronic Inflammatory Bowel Diseases.
Journal: Visceral medicine
Published: October 14, 2019
Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review.
Journal: BMC gastroenterology
Published: July 23, 2019
Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn's disease and ulcerative colitis.
Journal: Zeitschrift fur Gastroenterologie
Published: April 10, 2019
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis.
Journal: Inflammatory bowel diseases
Published: June 14, 2018
The metabolic capacity of lipid droplet localized acyl-CoA synthetase 3 is not sufficient to support local triglyceride synthesis independent of the endoplasmic reticulum in A431 cells.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: September 25, 2017
Last Updated: 09/26/2026